Drug Addiction Part 3

advertisement

Drug Addiction

Part 3

Karen Revere

Kian Eftekhari

Will Hiesinger

Risk of Addiction

(%)

Tobacco

Cocaine

Heroin

Alcohol

Cannabis

Ever Used (%) Dependence (%) Risk

75.6

16.2

1.5

91.5

46.3

24.1

2.7

0.4

14.1

4.2

* 31.9

16.7

23.1

15.4

9.1

Source: Anthony et al, 1994.

Courtesy of Charles A. Dackis, MD

Complications of Cocaine Use

Cerebrovascular Disorders

i.e. Ischemic or Hemorrhagic strokes

-Hemorrhage occurs about twice as frequently as ischemia.

-Hemorrhagic manifestations may be intraparenchymal or subarachnoid hemorrhage.

-Hemorrhage may occur within seconds of cocaine use or may lag cocaine use by as long as 12 hours. In many cases, it occurs within a few minutes.

-Ischemic strokes are likely due to vasospasm, vasculitis, or due to the procoagulant effect of the drug.

-Most cocaine-induced strokes occur in patients younger than 50 years.

The image was obtained 79 minutes from the sudden onset of right-sided weakness and numbness. T2weighted imaging and FLAIR show the lesion as an area of increased signal intensity with a periphery of signal loss (arrows C) and a surrounding rim of increased signal intensity, most likely due to vasogenic edema encasing the hematoma. CT obtained seven hours from symptom onset shows a left thalamic hematoma. Linfante, I,

Lilnas, RH, Caplan, LR, Warach, S,

Stroke 1999; 30:2263. Copyright ©

1999 Lippincott Williams and Wilkins.

So, why is this bad?

…because you DIE.

Hypertensive intracerebral hemorrhage

-The 30-day mortality from ICH ranges from 35 to 52 percent and one-half of these deaths occur within the first two days.

-Only a small number of patients function independently after the event.

Neuropsychiatric complications

-Neuropsychiatric complications occur in about 40% of cocaine users.

-Psychiatric disturbances include: depression, suicidal ideation, paranoia, violent antisocial behavior, catatonia, and auditory or visual hallucinations.

-A moderate proportion of addicts develop panic attacks.

-The paranoid symptoms are more severe and develop more rapidly with continuous use of cocaine.

Seizure

-Seizures occur in about 3% of cocaine users.

-The majority of seizures are single, generalized, induced by intravenous or crack cocaine

-Seizures are one of the few complications of cocaine use in which a direct relationship with dose has been shown.

-All routes of administration are associated with seizures, and seizures can be induced in some persons by small quantities of cocaine.

Cocaine use is associated with a variety of movement disorders: "crack dancers"

-Stereotyped behaviors

-Acute dystonic reactions (sustained, often painful muscular spasms, producing twisting abnormal postures)

-Choreoathetosis (brief, irregular contractions with twisting and writhing movements) and akathisia (extreme sensation of restlessness)

-Buccolingual dyskinesias ("twisted mouth" or "boca torcida")

-Exacerbation of Tourette's syndrome

Not Just the Brain

Treatment

-Treatment for cocaine addiction occurs primarily in the outpatient setting, and involves psychosocial treatment.

-Rates for long-term abstinence are less than 50 percent.

-Buprenorphine may be helpful for patients who are co-addicted to opiates.

-Disulfiram, topiramate, tiagabine, and modafinil have shown some promise for cocaine abstinence.

-Peer group self-help programs (such as Cocaine Anonymous) improve outcomes.

Reduced D

2

Binding in Cocaine Dependence

One of the most interesting findings in cocaine research . . . .

Raclopride binds D

2 receptors in the nucleus accumbens…

D

2 is also seen with morbid obesity, and addiction to alcohol, heroin & methamphetamine

Courtesy of Charles A. Dackis, MD

Modafinil Promotes Cocaine Abstinence

Modafinil is a Dopamine enhancing drug

Placebo Modafinil

50%

45%

40%

35%

30%

25%

20%

15%

10%

5%

0%

1 2 3 4 6 7 8

Longitudinal GEE models showed a significant main effect for cocaine abstinence in the modafinil group (odds ratio = 2.41, 95% CI 1.09-5.31, p = 0.03)

Courtesy of Charles A. Dackis, MD

Dackis et al.. Neuropsychopharmacology 2005

Download